NCT00477750 Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00466843 Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome Status UNKNOWN Phase PHASE2
NCT00466440 A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT00463385 A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00459186 The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00458848 Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00452387 Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC) Status TERMINATED Phase PHASE2
NCT00451178 A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only Status COMPLETED Phase PHASE2
NCT00450385 Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) Status TERMINATED Phase PHASE2
NCT00445900 Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00440349 Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis Status UNKNOWN Phase PHASE2
NCT00436839 Taxotere Prostate Cancer New Indication Registration Trial in China Status COMPLETED Phase PHASE3
NCT00433459 Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00430118 Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00428142 Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00423098 Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare Status COMPLETED Phase PHASE2
NCT00419926 Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients Status COMPLETED Phase PHASE4